Status:
RECRUITING
Determining the Effect of Food Ordering on Blood Glucose In Gestational Diabetes Mellitus (DEFI-GDM)
Lead Sponsor:
Queen's University, Belfast
Collaborating Sponsors:
Imperial College London
Conditions:
Gestational Diabetes Mellitus (GDM)
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to determine whether the sequence of macronutrient consumption affects post-prandial glycaemia in women with gestational diabetes mellitus. The main questions it ai...
Detailed Description
Gestational diabetes mellitus (GDM) is glucose intolerance with onset or first diagnosis during pregnancy, affecting around 1 in 10 pregnancies in the United Kingdom (UK). Women with GDM are 10 times ...
Eligibility Criteria
Inclusion
- Pregnant women with gestational diabetes mellitus
- Aged 18-50 years old
Exclusion
- History of type 1 or type 2 diabetes mellitus
- Dietary restrictions or clinically confirmed food allergies that may affect study requirements
- Pharmacologically managed GDM at the point of study entry
- Hyperemesis gravidarum at the point of study entry (i.e. prolonged/severe nausea and vomiting)
- Using antiemetic medication (e.g. dimenhydrinate, prochlorperazine, promethazine)
- Any other problems or medical conditions that would substantially limit their ability to complete the study requirements
- Participants can be recruited onto the study if they have previously had GDM in another pregnancy. Participants can also be recruited if they are involved in other research studies, but this will depend on the study type and the decision will be made by the Chief/Principal Investigator.
Key Trial Info
Start Date :
December 11 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2027
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT06896799
Start Date
December 11 2025
End Date
February 1 2027
Last Update
December 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Public Health, Institute of Clinical Sciences A
Belfast, United Kingdom, BT12 6BA